Boosting immunity: new vaccines for children

References

• Baxter R, Baine Y, Kolhe D, Baccarini CI, Miller JM, Van der Wielen M (2015) Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial. Pediatr Infect Dis J 34(11): 1236–43. doi: https://doi.org/10.1097/INF.0000000000000866 Crossref, Medline, Google Scholar
• Christensen H, Trotter CL, Hickman M, Edmunds WJ (2014) Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ 349: g5725. doi: https://doi.org/10.1136/bmj.g5725 Crossref, Medline, Google Scholar
• Frosi G, Biolchi A, Lo Sapio M et al. (2013) Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine 31(43): 4968–74. doi: https://doi.org/10.1016/j.vaccine.2013.08.006 Crossref, Medline, Google Scholar
• Holst J, Oster P, Arnold R et al. (2013) Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother 9(6): 1241–53. doi: https://doi.org/10.4161/hv.24129 Crossref, Medline, Google Scholar
• Jeppesen CA, Snape MD, Robinson H et al. (2015) Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect 71(1): 43–52. doi: https://doi.org/10.1016/j.jinf.2015.02.006 Crossref, Medline, Google Scholar
• Ladhani SN, Beebeejaun K, Lucidarme J et al. (2015) Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis 60(4): 578–85. doi: https://doi.org/10.1093/cid/ciu881 Crossref, Medline, Google Scholar
• Public Health England (2015) Meningococcal Meningitis and septicaemia notifiable. http://tinyurl.com/nsm4bqn (accessed 12 October 2015) Google Scholar
• Vesikari T, Esposito S, Prymula R et al. (2013) Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 381(9869): 825–35. doi: https://doi.org/10.1016/S0140-6736(12)61961-8 Crossref, Medline, Google Scholar